Technology & Science
Nov. 23, 1999
Genentech Settlement Could Spur More Suits
SAN FRANCISCO - Genentech Inc.'s $200 million settlement of a bitter patent infringement case involving human growth hormone research allegedly stolen from the University of California has significant implications nationally for universities seeking to raise royalties on their scientific inventions.
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In